HNX:MKV Revenue

In the year 2025, Cai Lay Veterinary Pharmaceutical JSC had annual revenue of 148.87B VND with 39.08% growth. Cai Lay Veterinary Pharmaceutical JSC had revenue of 39.47B in the quarter ending December 31, 2025, with 59.52% growth.

Revenue

148.87B

Revenue Growth

+39.08%

P/S Ratio

0.83

Revenue / Employee

1.43B

Employees

104

Market Cap

124.00B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	148.87B	41.83B	39.08%
Dec 31, 2024	107.04B	-3.87B	-3.49%
Dec 31, 2023	110.91B	-8.73B	-7.30%
Dec 31, 2022	119.63B	17.22B	16.82%
Dec 31, 2019	102.41B	-32.17B	-23.90%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2010	Pro	Pro	Pro
Jan 1, 2010	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
SPM Corporation	253.96B
Lamdong Pharmaceutical JSC	243.91B
Phong Phu Pharmaceutical JSC	139.83B
Ben Tre Pharmaceutical JSC	860.40B
Vimedimex Medi-Pharma JSC	1,172.99B
Mediplantex National Pharmaceutical JSC	367.08B
Vidipha Central Pharmaceutical JSC	950.89B
Central Pharmaceutical Joint Stock Company No3	438.01B

Revenue Rankings